For this year Roche's revenue will be around 61,6 billion CHF. This is according to the average of the analysts' estimates. This is slightly more than 2019's revenue of 61,47 billion CHF.
The analysts expect for 2020 a net profit of 16,9 billion CHF. Most of the analysts anticipate on a profit per share of 19,67 CHF. Based on this the price/earnings-ratio is 15,68.
Per share the analysts anticipate on a dividend of 9,26 CHF per share. Thus the dividend yield equals 3 percent. The average dividend yield of the pharmaceutical companies equals a limited 0,38 percent.
Roche's market capitalization is around 214,16 billion CHF. The Roche stock was the past 12 months quite unstable. Since last October the stock is 15 percent higher. This year the stock price moved between 266 and 358 CHF.
Click here for dividend Roche. At 17.37 the stock trades 3,49 percent lower at 308,4 CHF.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.